Google TrendPOSICIONES DE ATLÉTICO DE MADRID CONTRA MANCHESTER UNITED (5000+) — Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Effects of dapagliflozin" (30 stories)

Top Headline Story

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension
Lead StoryAmerican Heart Association Journalsgeneral
Dec 5, 2025

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9zN2RlYzQ5R21KTUI4bXpEaTMyQTJta28yQmtLZEVmNWc4cnRtbXgwMVdOOEdyWXJNSWVoSmVwcmlvYmNhTEVLcWVvWVgyTFlTcTlqcHpNR2hLT2FaSG10cVhGU2xDVDY3YlBJRm54TG9HVWs?oc=5" target="_blank">Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Real-time search volume
5000+24m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

2000+24m ago

devils vs red wings

Devils at Red Wings projected lineups

5000+24m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

200+34m ago

luis díaz

Max Eberl knows Luis Díaz will start scoring again for Bayern Munich

Search Results for "Effects of dapagliflozin"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways
Naturegeneral

Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0VjY3cXdleW9rWkw1Q2tKeF9nQWZ2SF9DUVpRRVlSWEMxSWZVNEtxUnE5QkpvdkRYZ3dqY2JWUDNHMG11bDItUmNUTmMwSnY2eTVwNWd3LTFyYlB0czNr?oc=5" target="_blank">Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways</a>  <font color="#6f6f6f">Nature</font>

Type 1 Diabetes-Induced Kidney Disease Treated with Phase III Trial Drug
Inside Precision Medicinegeneral

Type 1 Diabetes-Induced Kidney Disease Treated with Phase III Trial Drug

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNRHFJYWJ3bUVqRVRsbTVYcXJnMHRJa21SRWRRUU9RaWNWYlczRFA5R3JzczgyWnJfeDZqZzlNX3BINEVaa1B6RHptQk9HbHZKXzZybjVZVGtmR1l0UWk3TDZ0Sm9lMTBSVGZyZU5ibGZjVU1uZTNVT0pMSGxhNk1wcnNySUNkV2V0TkUzS2ZKUy1veFM3WF8ybGRDUGtMMzBCbXFMLUJFVEhvUHhRU1ZNUi1sYnl1SHRwTzAtbkV1bWFoR3dJQU5QcVhSUFo1UQ?oc=5" target="_blank">Type 1 Diabetes-Induced Kidney Disease Treated with Phase III Trial Drug</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Dapagliflozin Shows Cardioprotective Effect With CKD
DocWireNewsgeneral

Dapagliflozin Shows Cardioprotective Effect With CKD

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQNmdNUEo5MTNRT2dRdmQyUTlvc0M2ZmJKVkhIYThadzdJVTRrVlpyRDBTMmE0WXB2NE9KRnhiMU1CMGo1clMwQUVGY21SYkpidWg4VElxOUZ3X0xCRnlYZXNWRmxraVRObXI4U2VxRmdPMjFGUmNNQV84REZjZFNBc25NQW1tbG1MdlloTlBn?oc=5" target="_blank">Dapagliflozin Shows Cardioprotective Effect With CKD</a>  <font color="#6f6f6f">DocWireNews</font>

Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease
NEJM Evidencegeneral

Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9fNE1xMWlxN25KTVc0cTUzaDJNNDFyeXU5UUFraXFGUWJDS3c4RjNYSE5ibTJWWDBHWXAtR29GbDVLZ2FnUmp2UDFMSWxqLUEzeGl4M3RsbHpHd3BDUUJrcTFKbF9IUXM?oc=5" target="_blank">Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease</a>  <font color="#6f6f6f">NEJM Evidence</font>

Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India
Cureusworld

Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxOaXgweFd1bXp3bUp6ZFFOVmRHZ2RnRDdNZGtDZkhhak4xd3VmeUVmcWJ6a1NJa0Z4c2lmTTZybk5RNkhQWVJOWHg4RkQ5V0I2b1plaTdUa3lfOWRNeFFiYzBqYzd3TWhacGVqOENDX1JtNWNYa1hRVGJ5ODhLT2x5c1I4Zi1vWTZMbTVXQXdHV0NnbzlxSng0WlNyTEZHdHplN2tFa1BVV2h0MUZkeXlrTEQ4amNwbWpxQWs4Rm1CX2s3UHRhbXhDODdzQTBwVkhfNGtJVzdfOTVZVzA?oc=5" target="_blank">Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India</a>  <font color="#6f6f6f">Cureus</font>

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
Naturetech

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JOVVQM1pkdlR2MGs3RkVCRjJtOVVPUmV6WmwzeVpuNzdrbDFSTi1HcDlVZm1HUTVvcnRXM2ZXMWJ4VXkzdnFDZV9EcnZJX1Rwa0Z2a0c4c0VjdXdVQ3pV?oc=5" target="_blank">Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin - Five Years since CKD Approval: Revisiting 5 Milestones in CKD Care
Medical Dialoguesgeneral

Dapagliflozin - Five Years since CKD Approval: Revisiting 5 Milestones in CKD Care

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin - Five Years since CKD Approval: Revisiting 5 Milestones in CKD Care</a>  <font color="#6f6f6f">Medical Dialogues</font>

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial
The Lancetgeneral

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPRzA0ekVDODBZdi1CRk5fb21JYVJUU2pELUxnd01KaUZCQVhFaG5NVDRmV0tZbzhFMDhuN3cybi1iQTljaHI1aEJhaHRyZjRJWm1FSVZXQjFwMjZYZ1BEWWg2N3dlNTB5d0I5NXN1a29lTUQ4U3R2UXhaQkdab0ZVWW5vMDZ6NzYyeWxxYVhaZlhhZ3dhRWc?oc=5" target="_blank">Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial</a>  <font color="#6f6f6f">The Lancet</font>

The protective effects of dapagliflozin on cisplatin-induced ovarian toxicity via NRF2-HO-1 pathway and TNF-α/Cas3 signaling
Naturegeneral

The protective effects of dapagliflozin on cisplatin-induced ovarian toxicity via NRF2-HO-1 pathway and TNF-α/Cas3 signaling

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5zeTF5Y20yTUhkU1ZJMTE2aWcxc2ZkdklRZXRYT1o5TmVhN3M1djFTVnU1Z3BWcUd1RjI1VFNBbUdvVmVMU2llUXNNWEJXZDAzdndfVFNoSkZfSUo4eUhr?oc=5" target="_blank">The protective effects of dapagliflozin on cisplatin-induced ovarian toxicity via NRF2-HO-1 pathway and TNF-α/Cas3 signaling</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta
Medical Dialoguesgeneral

Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin Metformin in T2D: Six Potential Benefits Beyond Glucose Lowering-Dr Setu Gupta</a>  <font color="#6f6f6f">Medical Dialogues</font>

Dapagliflozin in Heart Failure: Cardiologist's Practical Perspective
Medical Dialoguestech

Dapagliflozin in Heart Failure: Cardiologist's Practical Perspective

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin in Heart Failure: Cardiologist's Practical Perspective</a>  <font color="#6f6f6f">Medical Dialogues</font>

Independent effects of Metformin and Dapagliflozin on Fetuin-A, hepatic and pancreatic fat, and hepatic fibrosis in Asian Indians with type 2 diabetes
Naturegeneral

Independent effects of Metformin and Dapagliflozin on Fetuin-A, hepatic and pancreatic fat, and hepatic fibrosis in Asian Indians with type 2 diabetes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE42cFBvS0lDODVkbkRlYWxIRHJjRGJjZnQ2cl9iMDJtV09KS3dkVGx1U0JBUGxobDZabXJmMEJZUlJCRmRXSnVUYlZDdGt1LW1MdUFib0tkUHFTcVdZSmFj?oc=5" target="_blank">Independent effects of Metformin and Dapagliflozin on Fetuin-A, hepatic and pancreatic fat, and hepatic fibrosis in Asian Indians with type 2 diabetes</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial
American Heart Association Journalstech

Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE56SkJrUk90Zk1BWE40RUpadW1QX3o0TkNzWlo5c1VodHVxbWY2TzJzMjRUNm1CZGc4TkZjYUxJS1lKVTFyX0pHY3BMRUVJUDFDMVRnWWNVd0RHTTdNTTVIVFdwdGNmc2JnZXNfVENzMUlKYUU?oc=5" target="_blank">Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin
Naturegeneral

Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CQUY4TDduN0VDYU1MNVVOc29zaGx6akluckRscTRUMjhHZjJSVlY5UExqOUdObWlIamFFYldNcEJwN0tyeWZZOFNsZFNxOTBPNnVmc3FPd1pqQTZESVZv?oc=5" target="_blank">Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin</a>  <font color="#6f6f6f">Nature</font>

Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction
American Heart Association Journalstech

Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9FVEFQbXBfNS1fUEg3dEdpSGQ5SW1kR2JFTXVrZ3dXTmcyeHV5NG5BVGw4SGw5Q2ZpMVlTSERFeDhYd2x3SXVJdDVGZEEzSXhsZVVTT29YTDN6NTZka3JISV94VVEzOHV4MExfVlFqMHZqUjg?oc=5" target="_blank">Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats
Naturegeneral

Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83d2JIckd1Qkl3R294TWdOUmJmaVNfSEZKNzlZUFZxS2tjc3VsY1NPQmxDNm9KTHc2anZyaTh1Z2toVWV2ZDMtdk5XeWVPczladzFzei1GZHpmQXBKdXdV?oc=5" target="_blank">Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats</a>  <font color="#6f6f6f">Nature</font>

Lessons from dapagliflozin in the UK: status and effects of “hold the ring” injunctions
JUVE Patentworld

Lessons from dapagliflozin in the UK: status and effects of “hold the ring” injunctions

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOTEdhYjZmNVpWNlFoZ09XclItdzRXVjhuX3piY1FoMlduNUNMT2F4Q0ZYR05Kemh1NnlNeHp1b1AxZ2pIM0k4U1VXZnZ0aHJSb21BYXFrMDlsQnZIZWJSNWZFZVRfR1FKMThfaVBDb3p2VHNxVmZoeDZrMTVoTEVkSnhwZXQ2dWlKaGg3S0R4ay1uT2IzTUMxbXBiUDZYNFRraWtPSVRTbUJBb2xKTlkzcDRPRWhOLXlyNzFTVVRmM3pac296YzlYc2Mza08zN0xJTlNRVWV2cWhfZw?oc=5" target="_blank">Lessons from dapagliflozin in the UK: status and effects of “hold the ring” injunctions</a>  <font color="#6f6f6f">JUVE Patent</font>

Effects of dapagliflozin on myoglobin efflux from cardiomyocyte during myocardial ischemia/reperfusion in anesthetized rats
Naturegeneral

Effects of dapagliflozin on myoglobin efflux from cardiomyocyte during myocardial ischemia/reperfusion in anesthetized rats

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBQa29ySXZBSzFIMHlIcEhUM2htUDhIU3g3d3NldUMtUEw1SWVxR3VJMU1jaHl1eUFNU3lGMzVhQjZ3dm5Rdnc0VGNIZXhsUVZkTFdpYTg4d0VWWW5NRUg4?oc=5" target="_blank">Effects of dapagliflozin on myoglobin efflux from cardiomyocyte during myocardial ischemia/reperfusion in anesthetized rats</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin & Kidney: Top 5 New Evidence Highlights in 2026
Medical Dialoguesgeneral

Dapagliflozin & Kidney: Top 5 New Evidence Highlights in 2026

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin & Kidney: Top 5 New Evidence Highlights in 2026</a>  <font color="#6f6f6f">Medical Dialogues</font>

Dapagliflozin in Patients with Chronic Kidney Disease
NEJMgeneral

Dapagliflozin in Patients with Chronic Kidney Disease

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5id3dZWDRmSXk2LWQzUzBQcEpIUEZnaWFNZGdZNWpNYzZPVTNyUWZGVGNDSXdaeUVkWkVEX1BsNE5iaW5kVEl4OTRwWXNubUYzZ2dkVUdLZGV4V1oySXFyeg?oc=5" target="_blank">Dapagliflozin in Patients with Chronic Kidney Disease</a>  <font color="#6f6f6f">NEJM</font>

Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease
Naturegeneral

Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9pWVlGYTFXQzB2SjRFUGpBNmtubUtGUXJWdnVxdlZXWWVWMV96eGxXMDhmQ2lub1Fvc2JnaGdLcEZybDlNenNPV2dhaFdUNGJLczlpNzRidkZMNzlhc2Rn?oc=5" target="_blank">Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin in Non-Diabetic Kidney Disease (N-DKD): A Nephrologist's Practical Perspective
Medical Dialoguesgeneral

Dapagliflozin in Non-Diabetic Kidney Disease (N-DKD): A Nephrologist's Practical Perspective

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin in Non-Diabetic Kidney Disease (N-DKD): A Nephrologist's Practical Perspective</a>  <font color="#6f6f6f">Medical Dialogues</font>

Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial
Wiley & Sonsgeneral

Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE11OWxGQ2NyRTREVDdzZ2lMTVRtSklxZDNDUGFBbTVvTXE3UHRDWHFPZEd3VS0ydk9mUzNHVTRYNzh4aWRiME1zWUtNYmc4Ylk5SVppVGxIU2VnZmg5UmI5ekJRbU01YUc1cVpXU1BLbzA4N2dq?oc=5" target="_blank">Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trial</a>  <font color="#6f6f6f">Wiley & Sons</font>

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
Naturegeneral

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE04VEJSbDZubldtbHhzaExmUVh6blFfOUY5RExENzJQY20zOXhFejlSLThwbVhfcFAtZTVMRFZNR0o3WklNZXhvYk5TNUJxbHZrQ0g4Y3o2YzVnTjZ5bzRZ?oc=5" target="_blank">The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD</a>  <font color="#6f6f6f">Nature</font>

Dapagliflozin Shows Added Cardiac Benefits Over Linagliptin in T2DM with Heart Failure: Study
Medical Dialoguestech

Dapagliflozin Shows Added Cardiac Benefits Over Linagliptin in T2DM with Heart Failure: Study

<a href="https://news.google.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?oc=5" target="_blank">Dapagliflozin Shows Added Cardiac Benefits Over Linagliptin in T2DM with Heart Failure: Study</a>  <font color="#6f6f6f">Medical Dialogues</font>

Dapagliflozin Lowers Hospitalization Risk in Patients With CKD Despite Diabetes Status
The American Journal of Managed Caregeneral

Dapagliflozin Lowers Hospitalization Risk in Patients With CKD Despite Diabetes Status

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNb1hwU1dCbEM2eDhTMzhwTERqaTlqX1ZYUXR1REtDMXlBMjZmdVlWMnJyREFPRFV1UGc3alFWX1FPUWVHSXAtRkplQ25ncWtnalVTM1NJLTdXRlVwbmtYWVFFMzRnaVRsQUczdXdoaUptQVloOWp2a2RWdkRYajdyZ2RzOHkxUkw1TlJnX041Ukh3MUM2Mk5YUlVySDBpeENfZlozTUM5S25Cc19hT3c?oc=5" target="_blank">Dapagliflozin Lowers Hospitalization Risk in Patients With CKD Despite Diabetes Status</a>  <font color="#6f6f6f">The American Journal of Managed Care</font>

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
NEJMtech

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5XWVJZNlJ4bWtYd0lXeGdqUDFfbVBkT1hQQTlKdXZpdnhMZmtPRl9zRERLZW1EU1VZdy1SWkg5QkRidHN3LWFOQlItT1NTWV9MSkIxNXF2bmlObXpaZzV2Tw?oc=5" target="_blank">Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction</a>  <font color="#6f6f6f">NEJM</font>

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
The Lancetgeneral

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOU2c2VVlUNS1CRENHQ2hBOXRLdEZhS1pRanMteTlHZml3dWtKZHFmY2ZlcThtT1l4QVVDaVAtVDhUWHhvZjRvNjFDQ0JzSnpkaHVld1dma2hmTGtoTVJWSXdDYUx0OGFiSl96ams3V2pFVVRack9jdDVmSUpFbGVOTEtRUHJkTkQ1SXRZZjVIYWY?oc=5" target="_blank">Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial</a>  <font color="#6f6f6f">The Lancet</font>

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction:
American Heart Association Journalstech

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction:

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9aY0UzVGpHOFk5aUVXQVB3eThUWGhjbldMclgwaHZyVkN4eEJBcW9UaVZxTUlUdjBiVVRaM3d4WVhscU5PYk9fMV9iQjVCUFhXWUQtOGs5Zk5FWEU4cEt0c3ppdmEyZGZBcDNIRURhX3RuTWM?oc=5" target="_blank">Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction:</a>  <font color="#6f6f6f">American Heart Association Journals</font>

"Effects of dapagliflozin" — Live Google News Trends & Headlines